Last updated on June 2019

Study to Evaluate DNL201 in Subjects With Parkinson's Disease


Brief description of study

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral doses of DNL201 in subjects with Parkinson's disease.

Clinical Study Identifier: NCT03710707

Find a site near you

Start Over

CNS Network

Long Beach, CA United States
  Connect »

Bioclinica Research

Orlando, FL United States
  Connect »

Henry Ford Hospital

Farmington Hills, MI United States
  Connect »

QUEST Research Institute

Farmington Hills, MI United States
  Connect »

University of Pennsylvania

Philadelphia, PA United States
  Connect »

Henry Ford West Bloomfield Hospital

Farmington Hills, MI United States
  Connect »

Inland Northwest Research

Spokane, WA United States
  Connect »